摘要
目的观察分析苯磺酸左旋氨氯地平治疗COPD伴发的高血压病疗效。方法随机将COPD伴发的高血压病患者1 00例分为治疗组和对照组各50例,对照组服用硝苯地平,治疗组服用苯磺酸左旋氨氯地平。结果治疗组的总有效率为94.0%,对照组的总有效率为72.0%,两组差异具有统计学意义(P<0.05)。治疗组2例出现面红、头晕,对照组4例出现面红、头痛。以上不良反应均自行消失。结论苯磺酸左旋氨氯地平治疗COPD伴发的高血压病,疗效满意,安全可靠,毒副作用少,可以临床首选使用。
Objective Observation and analysis of LevamLodipine besylate in treating COPD accompanied hypertension. Methods Random of our hospital COPD accompanied with hypertension patients 100 cases, divided into treatment group, control group 50 cases, control group with nifedipine, treatment group with levoamLodipine besylate. Results The total effective rate in treatment group was 94.0%, control group in the total efficiency was 72.0%, the difference was statistically significant （P〈0.05）. The treatment group of 2 cases appear red, dizziness, control group of 4 cases appear red, headache. The above adverse reactions were lost. Conclusion The levamLodipine besylate in treatment of COPD with hypertension curative effect, safety and reliability, less toxic side effect, is worth the clinical to its preferred use.
出处
《当代医学》
2013年第4期152-152,共1页
Contemporary Medicine
